Byetta from AstraZeneca is an insulin sensitizer that mimics proteins from Gila monster saliva to help Type 2 diabetics maintain glucose levels.
Benefits
- Insulin control
- FDA approved
Applications
- Prescription medicine
UN Sustainable Development Goals Addressed
-
Goal 3: Good Health & Wellbeing
The Challenge
Individuals diagnosed with diabetes face a variety of issues that need to be managed daily. Diabetes is a chronic disease where a person cannot regulate the amount of sugar (glucose) in their blood. With use of injections, diabetics are able to artificially control their blood sugar, helping to keep the disease in check.
Innovation Details
Byetta is an insulin sensitizer, which is part of a new class of drugs called incretin mimetics. These drugs mimic incretin s, which the body usually naturally produces to help stimulate insulin release after a meal. Byetta uses synthetic copies of a hormone from the saliva of the Gila monster (exendin-4), which serves a similar function, to improve blood sugar control in diabetics.
Biological Model
The Gila monster is an opportunistic carnivore that eats large meals when they are available and fasts for long periods in between. It has a hormone in its saliva, exendin-4, that helps it maintain its blood sugar levels during long periods of food scarcity.